Association between serum YKL-40 and chronic obstructive pulmonary disease

Y. Ma (CHENGDU, China)

Source: International Congress 2017 – COPD biomarkers
Session: COPD biomarkers
Session type: Thematic Poster
Number: 3600
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Ma (CHENGDU, China). Association between serum YKL-40 and chronic obstructive pulmonary disease. 3600

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between serum leptin, nutritional status and severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008

The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004

Serum leptin levels in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 259s
Year: 2002

Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Serum magnesium levels of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 107s
Year: 2003

Clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Association of extracellular Hsp70 with the severity of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020


Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Serum amyloid A in patients with stable chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018



Serum periostin in obstructive airways disease
Source: Eur Respir J 2016; 47:1383-1391
Year: 2016



PP310 – Association of testosterone with lung function in patients with chronic obstructive lung disease
Source: ERS Lung Science Conference 2021
Year: 2021

Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease
Source: ERJ Open Res, 4 (4) 00069-2018; 10.1183/23120541.00069-2018
Year: 2018



Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 586s
Year: 2005

Periostin levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

Genetically elevated C-reactive protein and chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Environmental and genetic risk factors for asthma and COPD
Year: 2009


Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with  chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018




Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008